Development of tuberculosis in a patient treated with infliximab who had received prophylactic therapy with isoniazid
Parra Ruiz, J.; Ortego Centeno, N.; Raya Alvarez, E.
Journal of Rheumatology 30(7): 1657-1658
2003
ISSN/ISBN: 0315-162X PMID: 12858475 Document Number: 558764
Document emailed within 1 workday
Related Documents
Masobe, P.; Lee, T.; Price, M. 1995: Isoniazid prophylactic therapy for tuberculosis in HIV-seropositive patients--a least-cost analysis South African Medical Journal 85(2): 75-81Umeda, N.; Inada, Y.; Mamoto, T. 2014: Development of eosinophilic pneumonia in a patient with latent tuberculosis infection resulting from isoniazid Kekkaku: 89(10): 777-780
O'Brien, R.J.; Long, M.W.; Cross, F.S.; Lyle, M.A.; Snider, D.E. 1983: Hepatotoxicity from isoniazid and rifampin among children treated for tuberculosis Pediatrics 72(4): 491-499
Lo Schiavo, A.; Cozzi, R.; Alfano, R.; Romano, F.; La Montagna, M.; Caccavale, T.; Capasso, R.; Mea, E.E.; Caccavale, S. 2014: A case of tuberculosis cutis colliquativa treated with rifampicin and isoniazid Acta Dermatovenerologica Croatica: Adc 22(2): 160-161
Volosevich, G.V. 1989: Hepatitis during rifampicin and isoniazid treatment of a patient with generalized tuberculosis Problemy Tuberkuleza 9: 72-73
Belianin, I.I. 2004: Decreased resistance of multiresistant mycobacteria to isoniazid during the treatment of experimental tuberculosis with ozone and isoniazid Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 2004(3): 95-98
Kumar, L.; Gupta, R.; Puri, M.M.; Jaiswal, A.; Srinath; Murar, A.; Behera, D. 2011: Unilateral and painless development of isoniazid induced gynecomastia during re-treatment of pulmonary tuberculosis Journal of the Association of Physicians of India 59: 733-735
Hinaut, G.; Bosio, A.M.; Estampes, B. 1970: Severe hypoprothrombinemia in a tubercular patient treated by combined rifampicin, isoniazid, streptomycin and prothionamide Revue de Tuberculose et de Pneumologie 34(2): 291-295
Aamodt, T. 1970: Liver function during tuberculosis therapy with streptomycin, isoniazid and aminosalicylate Nordisk Medicin 83(24): 774
Sanli, H.; Ataman, S.; Akay, B.ü N.; Yilmaz, A.; Yildizlar, D.; Gürgey, E. 2007: Mycosis fungoides in a patient with ankylosing spondylitis during infliximab therapy Journal of Drugs in Dermatology: Jdd 6(8): 834-836
Havel, J.; Aboutalebi, S.; Doughty, L.; Wirges, M. 2008: Development of systemic lupus erythematosus in a patient with rheumatoid arthritis following treatment conversion of infliximab to adalimumab Journal of Drugs in Dermatology: Jdd 7(8): 796-798
Khawcharoenporn, T.; Apisarnthanarak, A.; Manosuthi, W.; Sungkanuparph, S.; Mundy, L.M. 2012: Isoniazid preventive therapy and 4-year incidence of pulmonary tuberculosis among HIV-infected Thai patients International Journal of Tuberculosis and Lung Disease: the Official Journal of the International Union Against Tuberculosis and Lung Disease 16(3): 336-341
Mills, H.L.; Cohen, T.; Colijn, C. 2011: Modelling the performance of isoniazid preventive therapy for reducing tuberculosis in HIV endemic settings: the effects of network structure Journal of the Royal Society Interface 8(63): 1510-1520
van Halsema, C.L.; Fielding, K.L.; Chihota, V.N.; Russell, E.C.; Lewis, J.J.C.; Churchyard, G.J.; Grant, A.D. 2010: Tuberculosis outcomes and drug susceptibility in individuals exposed to isoniazid preventive therapy in a high HIV prevalence setting Aids 24(7): 1051-1055
Amlabu, V.; Mulligan, C.; Jele, N.; Evans, A.; Gray, D.; Zar, H.J.; McIlleron, H.; Smith, P. 2014: Isoniazid/acetylisoniazid urine concentrations: markers of adherence to isoniazid preventive therapy in children International Journal of Tuberculosis and Lung Disease: the Official Journal of the International Union Against Tuberculosis and Lung Disease 18(5): 528-530
Assebe, L.Fekadu.; Reda, H.Lemma.; Wubeneh, A.Desta.; Lerebo, W.Terefe.; Lambert, S.Maria. 2015: The effect of isoniazid preventive therapy on incidence of tuberculosis among HIV-infected clients under pre-ART care, Jimma, Ethiopia: a retrospective cohort study Bmc Public Health 15: 346
Sasaki, Y.; Yamagishi, F.; Suzuki, K.; Kuriyama, T. 1997: Survival and pulmonary hemodynamics in patients with sequelae of pulmonary tuberculosis who received home oxygen therapy Nihon Kyobu Shikkan Gakkai Zasshi 35(5): 511-517
Garcia, E.Benito.; Michaud, K.; Wolfe, F. 2006: Gastrointestinal prophylactic therapy among patients with arthritis treated by rheumatology specialists Journal of Rheumatology 33(4): 779-784
Heldmann, F.; Brandt, J.; van der Horst-Bruinsma, I.E.; Landewe, R.; Sieper, J.; Burmester, G.R.; van den Bosch, F.; de Vlam, K.; Geusens, P.; Gaston, H.; Schewe, S.; Appelboom, T.; Emery, P.; Dougados, M.; Leirisalo-Repo, M.; Breban, M.; Listing, J.; Braun, J. 2011: The European ankylosing spondylitis infliximab cohort (EASIC): a European multicentre study of long term outcomes in patients with ankylosing spondylitis treated with infliximab Clinical and Experimental Rheumatology 29(4): 672-680
Weigel, B. 1976: Changes of the tuberculosis of the central nervous system since the introduction of prophylactic BCG vaccination and tuberculostatic therapy Zentralblatt für Allgemeine Pathologie U. Pathologische Anatomie 120(1): 21-33